[go: up one dir, main page]

HUP0201765A3 - Taste masked pharmaceutical liquid formulations - Google Patents

Taste masked pharmaceutical liquid formulations

Info

Publication number
HUP0201765A3
HUP0201765A3 HU0201765A HUP0201765A HUP0201765A3 HU P0201765 A3 HUP0201765 A3 HU P0201765A3 HU 0201765 A HU0201765 A HU 0201765A HU P0201765 A HUP0201765 A HU P0201765A HU P0201765 A3 HUP0201765 A3 HU P0201765A3
Authority
HU
Hungary
Prior art keywords
liquid formulations
taste masked
pharmaceutical liquid
masked pharmaceutical
taste
Prior art date
Application number
HU0201765A
Other languages
English (en)
Original Assignee
Orto Mcneil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orto Mcneil Pharmaceutical Inc filed Critical Orto Mcneil Pharmaceutical Inc
Publication of HUP0201765A2 publication Critical patent/HUP0201765A2/hu
Publication of HUP0201765A3 publication Critical patent/HUP0201765A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0201765A 1999-07-09 2000-06-21 Taste masked pharmaceutical liquid formulations HUP0201765A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14301999P 1999-07-09 1999-07-09

Publications (2)

Publication Number Publication Date
HUP0201765A2 HUP0201765A2 (hu) 2002-11-28
HUP0201765A3 true HUP0201765A3 (en) 2004-05-28

Family

ID=22502238

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0201765A HUP0201765A3 (en) 1999-07-09 2000-06-21 Taste masked pharmaceutical liquid formulations

Country Status (25)

Country Link
US (2) US6482823B1 (hu)
EP (1) EP1194153B1 (hu)
JP (1) JP2003504335A (hu)
KR (2) KR100675809B1 (hu)
CN (1) CN1174740C (hu)
AR (1) AR027179A1 (hu)
AT (1) ATE265852T1 (hu)
AU (1) AU773555B2 (hu)
BR (1) BR0012326A (hu)
CA (1) CA2377916C (hu)
DE (1) DE60010464T2 (hu)
DK (1) DK1194153T3 (hu)
EE (1) EE05147B1 (hu)
ES (1) ES2219360T3 (hu)
HR (1) HRP20020119A2 (hu)
HU (1) HUP0201765A3 (hu)
IL (2) IL147510A0 (hu)
MX (1) MXPA02000331A (hu)
NO (1) NO20020086L (hu)
NZ (1) NZ516486A (hu)
PL (1) PL197812B1 (hu)
PT (1) PT1194153E (hu)
SK (1) SK322002A3 (hu)
TR (1) TR200200710T2 (hu)
WO (1) WO2001003698A1 (hu)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001080826A2 (en) * 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
MXPA03008056A (es) * 2001-03-05 2004-10-15 Johnson & Johnson Composiciones farmaceuticas liquidas con sabor oculto.
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004013047A2 (en) * 2002-08-02 2004-02-12 Eggs In The Pipeline, Llc. System for adding consumable enhancing additives to drinking water
US20080020096A1 (en) * 2003-08-01 2008-01-24 Blum Bradley J System for Adding Consumable Enhancing Additives to Drinking Water
JP4647493B2 (ja) * 2003-09-12 2011-03-09 株式会社龍角散 苦みマスキング粒状ゼリー飲料
US7378015B2 (en) * 2003-12-18 2008-05-27 The Clorox Company Filtered water enhancements
US7713482B2 (en) 2003-12-18 2010-05-11 The Clorox Company Control scheme for enhanced filtered water systems
CA2561855A1 (en) * 2004-04-12 2005-10-20 Pfizer Products Inc. Taste-masked drugs in rupturing multiparticulates
JP2006232789A (ja) * 2005-02-28 2006-09-07 Sawai Pharmaceutical Co Ltd 経口製剤用組成物及びその製造方法
US20060216355A1 (en) * 2005-03-28 2006-09-28 Donald Spector Encapsulated pharmaceuticals in a medium having non-encapsulated flavoring agents
US8247018B2 (en) * 2005-06-20 2012-08-21 Authentiform Technologies, Llc Methods for quality control
US7874489B2 (en) * 2005-06-20 2011-01-25 Authentiform Technologies, Llc Product authentication
WO2007002009A2 (en) * 2005-06-20 2007-01-04 Johnson & Johnson Product authentication
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
WO2008065504A1 (en) 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
WO2009136398A2 (en) * 2008-05-06 2009-11-12 Dexcel Ltd Stable benzimidazole formulation
CN101618217B (zh) * 2009-07-27 2011-12-28 洛阳君山制药有限公司 一种安胃片的包衣方法
KR101636958B1 (ko) * 2009-09-11 2016-07-06 주식회사 대웅제약 우루소데옥시콜린산-합성하이드로탈사이트-유드라짓 혼성체, 이를 함유하는 약학 조성물 및 그 제조방법
CA2783877A1 (en) * 2009-12-10 2011-06-16 A. Mark Schobel Ph sensitive compounds in taste masking within oral thin film strips
BR112012014962A2 (pt) * 2009-12-18 2016-04-05 Exodos Life Sciences Ltd Partnership métodos e composições para formulações líquidas e estáveis de fármacos
WO2014070958A1 (en) 2012-10-30 2014-05-08 Certirx Corporation Product, image, or document authentication, verification, and item identification
MX365914B (es) 2013-03-15 2019-06-20 Aprecia Pharmaceuticals LLC Forma de dosificación de topiramato dispersable rápidamente.
ES2761265T3 (es) 2013-03-15 2020-05-19 Aprecia Pharmaceuticals LLC Forma de dosificación de oxcarbazepina rápidamente dispersable
IL261756B2 (en) 2016-03-17 2023-11-01 Thiogenesis Therapeutics Inc Preparations for the controlled release of cysteamine and systemic treatment of disorders sensitive to cysteamine
KR102088315B1 (ko) 2017-10-23 2020-03-13 주식회사 웅진릴리에뜨 장용성 캡슐의 이취 마스킹 방법 및 이를 이용한 이취의 마스킹 처리가 이루어진 장용성 캡슐
CN111629714A (zh) * 2018-01-22 2020-09-04 强生消费者公司 打孔胶囊
WO2020104837A1 (en) 2018-11-21 2020-05-28 Rosemont Pharmaceuticals Limited Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN117503701A (zh) * 2023-12-08 2024-02-06 斯坦德医药研发(江苏)有限公司 左氧氟沙星口服混悬液制剂及制剂制造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62226926A (ja) 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
US5065094A (en) 1990-08-07 1991-11-12 Seagate Technology, Inc. Two terminal magnetoresistive sensor having DC blocking capacitor
FR2665635A1 (fr) * 1990-08-10 1992-02-14 Merck Sharp & Dohme Composition pharmaceutique fluide a base d'un complexe metallique et son procede de preparation.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5599556A (en) 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
FR2694751B1 (fr) 1992-08-14 1994-11-25 Bouchara Sa Nouveaux dérivés sulfonamides, leurs procédés de préparation et les compositions en renfermant.
US5614222A (en) * 1994-10-25 1997-03-25 Kaplan; Milton R. Stable aqueous drug suspensions and methods for preparation thereof

Also Published As

Publication number Publication date
PL352761A1 (en) 2003-09-08
ATE265852T1 (de) 2004-05-15
TR200200710T2 (tr) 2002-08-21
CN1360504A (zh) 2002-07-24
US6586012B2 (en) 2003-07-01
EE200200012A (et) 2003-02-17
US6482823B1 (en) 2002-11-19
KR20020031382A (ko) 2002-05-01
CN1174740C (zh) 2004-11-10
AR027179A1 (es) 2003-03-19
AU5880200A (en) 2001-01-30
IL147510A0 (en) 2002-08-14
KR20020029668A (ko) 2002-04-19
DE60010464D1 (de) 2004-06-09
DK1194153T3 (da) 2004-08-02
NZ516486A (en) 2003-10-31
ES2219360T3 (es) 2004-12-01
IL147510A (en) 2007-06-03
CA2377916C (en) 2008-03-11
EP1194153A1 (en) 2002-04-10
NO20020086D0 (no) 2002-01-08
JP2003504335A (ja) 2003-02-04
EP1194153B1 (en) 2004-05-06
CA2377916A1 (en) 2001-01-18
SK322002A3 (en) 2003-02-04
WO2001003698A1 (en) 2001-01-18
EE05147B1 (et) 2009-04-15
PT1194153E (pt) 2004-09-30
MXPA02000331A (es) 2002-06-21
HUP0201765A2 (hu) 2002-11-28
US20030064107A1 (en) 2003-04-03
AU773555B2 (en) 2004-05-27
KR100675809B1 (ko) 2007-02-01
HRP20020119A2 (en) 2003-12-31
PL197812B1 (pl) 2008-04-30
NO20020086L (no) 2002-03-05
BR0012326A (pt) 2002-03-12
DE60010464T2 (de) 2005-05-12

Similar Documents

Publication Publication Date Title
HUP0201765A3 (en) Taste masked pharmaceutical liquid formulations
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
IL147756A0 (en) Preserved pharmaceutical formulations
EP1450749A4 (en) AQUEOUS LIQUID PHARMACEUTICAL COMPOSITION WITH HIDDEN TASTE
CZ20011186A3 (cs) Stabilizovaný farmaceutický prostředek
SI1183026T1 (sl) Izboljsane farmacevtske spojine, vsebujoce ritonavir
HUP0203585A3 (en) Pharmaceutical combinations
EP1173216A4 (en) PHARMACEUTICAL FORMULATIONS
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them
GB9915231D0 (en) Pharmaceutical complex
GB9909154D0 (en) Pharmaceutical formulation
GB9926251D0 (en) Pharmaceutical formulation
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
SI1194153T1 (en) Taste masked pharmaceutical liquid formulations
EP1414417A4 (en) PHARMACEUTICAL FORMULATION
GB9919840D0 (en) Pharmaceutical formulation
GB9917772D0 (en) Pharmaceutical formulation
GB9910633D0 (en) Pharmaceutical formulation
GB9910636D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9930878D0 (en) Pharmaceutical formulation
GB9930700D0 (en) Pharmaceutical formulation
GB9917775D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees